Rocío Ferreiro Iglesias

Rocío Ferreiro Iglesias

IBD Unit | MD, PhD

Hospital Name & Address:   University Hospital. Choupana, s/n, 15706, Santiago de Compostela, Spain
Telephone:  +34 639 768 891


  • Licentiate in Medicine for the University of Santiago de Compostela, Spain
  • Specialist in Gastroenterology. Dept. of Gastroenterology. University Hospital of Santiago de Compostela (2007-2011)
  • Postrgraduate in Statitistics in Health Ssciences for Autonomus University of Barcelona (2012-2014).
  • PhD in Medicine (2013-2017) “Fecal calprotectin as predictor of relapse in patients with Inflammatory Bowel Disease in remission under maintenance anti-TNF therapy”
  • First certificate in English for Cambridge University


Work Experience

  • Inflammatory Bowel Disease Unit Department of Gastroenterology, University Hospital of Santiago de Compostela, Spain
  • Inflammatory Bowel Disease Unit. Department of Gastroenterology, Clinic Hospital, Barcelona


Clinical Study Experience

Principal Investigator in 6 IBD Projects of National Investigation or Clinical Trials, co- investigator in > 20 international and national projects 


  • 16 Articles in Scientific National and International Journals (11 Indexed in pubmed)
  • 12 Chapters of National and International Books.


Courses Meetings

  • > 70 Communications to National and International Congresses
  • As first or last author > 30 Communications to National and > 15 International Congresses



  • Coordinator of the Young GETECCU members (Spain)
  • Reviewer of 3 journals
  • Member of the organizing committee of 2 meetings
  • Winners of the top 10 posters of the 8th Congress of ECCO Vienna 2013
  • “Use of faecal calprotectin as predictor of relapse in patients under maintenance treatment with Infliximab”
  • Winners of the best oral communication of the Congress of SED Sevilla 2011
  • “Predictors of response to treatment with terlipressin and albumin in patients with cirrhosis and hepatorenal syndrome type I”.